DrugsControl Media Services
DrugsControl.org

News Detail

Orchid Pharma's 'Exblifep' granted EMA approval (30-01-2024)

Chennai, 30 Jan 2024: Orchid Pharma, based in Chennai, India, on Monday announced that its antibiotic invention, ‘Exblifeb,’ which incorporates Enmetazobactam, has received the European Medicines Agency’s (EMA) recommendation for marketing authorisation.

View Details
Source : Press Release
Orchid Pharma European Medicines Agency (EMA) Enmetazobactam Exblifep

Related News